Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?

This biotech stock could soar 30% or more over the next 12 months if some analysts are right.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Monday 5 October →